Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Vibroacoustic Study of Lung Development in Newborn Infants

for
Prematurity, Premature Birth, Premature Lungs,
Location: Washington DC
Sponsor: Level 42 AI, Inc.

Sex: All

Age: 0 - 2

Code: NCT05827250

Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: Washington D.C. DC, Richmond VA, Philadelphia PA,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase 1, Phase 2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Washington D.C. DC, Bethesda MD, Philadelphia PA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase 3, Recruiting

Optimal Pacing Rate for Cardiac Resynchronization Therapy

for
Atrial Fibrillation, Persistent
Location: Washington DC, Fairfax VA, Clinton MD
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06445439

Recruiting

Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

for
Pressure Ulcers Stage II, Pressure Ulcers Stage III,
Location: Washington D.C. DC, Baltimore MD, Pittsburgh PA,
Sponsor: ULURU Inc.

Sex: All

Age: 18 - 70+

Code: NCT05496296

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers

for
Oropharynx Cancer
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06554158

Recruiting

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

for
Advanced Alveolar Soft Part Sarcoma,
Location: Washington D.C. DC, Bethesda MD, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05333458

Phase 2, Recruiting

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

for
Congenital Antithrombin Deficiency
Location: Washington D.C. DC, New York NY, Durham NC, Peoria IL,
Sponsor: Octapharma

Sex: All

Age: 12 - 70+

Code: NCT04918173

Phase 3, Recruiting

Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *On Hold Due to Global Pandemic*

for
Ischemic Stroke, Hypertension
Location: Washington DC
Sponsor: MedStar Georgetown University Hospital

Sex: All

Age: 18+

Code: NCT04226157

Recruiting

Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

for
Oropharyngeal Cancers, HPV, Tonsil Cancer,
Location: Washington D.C. DC, Clinton MD
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06902623

Recruiting

Multimodal Perioperative Pain Management: ComfortSafe Program

for
Post-operative Pain, Post-operative Nausea and Vomiting,
Location: Washington DC
Sponsor: Georgetown University

Sex: All

Age: 21 - 70+

Code: NCT04046068

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Washington D.C. DC, Philadelphia PA, Durham NC,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Washington D.C. DC, Hyattsville MD, Charlotte NC,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05894239

Phase 3, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase 3, Recruiting

Bacterial Load for Integra™ in Operative Wounds

for
Wounds and Injuries
Location: Washington DC
Sponsor: Georgetown University

Sex: All

Age: 18 - 70+

Code: NCT04543240

Recruiting

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery

for
Prostate Cancer, Localized Malignant Neoplasm
Location: Washington DC
Sponsor: Georgetown University

Sex: Male

Age: 18 - 70+

Code: NCT01766492

Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Washington D.C. DC, Annapolis MD, Baltimore MD,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo

for
Mastectomy, Breast Cancer
Location: Washington DC
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT03504865

Phase 2, Recruiting

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

for
Ulcerative Colitis, Crohn Disease
Location: Washington D.C. DC, New York NY, New Haven CT,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05230173

Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Washington D.C. DC, Bethesda MD, Fairfax VA,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting